FDA Compounding Policy To Have Day In Court In December
This article was originally published in The Pink Sheet Daily
Executive Summary
Ten pharmacies challenging the agency's compounding policy say the lawsuit is an effort to stop "FDA's end-run on the Western States decision," which threw out restrictions on advertising for compounding products.